The modern healthcare and life sciences ecosystem is moving towards an increasingly open and data-centric approach to discovery science. This evolving paradigm is predicated on a complex set of information needs related to our collective ability to share, discover, reuse, integrate, and analyze open biological, clinical, and population level data resources of varying composition, granularity, and syntactic or semantic consistency. Such an evolution is further impacted by a concomitant growth in the size of data sets that can and should be employed for both hypothesis discovery and testing. When such open data can be accessed and employed for discovery purposes, a broad spectrum of high impact end-points is made possible. These span the spectrum from identification of de novo biomarker complexes that can inform precision medicine, to the repositioning or repurposing of extant agents for new and cost-effective therapies, to the assessment of population level influences on disease and wellness. Of note, these types of uses of open data can be either primary, wherein open data is the substantive basis for inquiry, or secondary, wherein open data is used to augment or enrich project-specific or proprietary data that is not open in and of itself. This workshop is concerned with the key challenges, opportunities, and methodological best practices whereby open data can be used to drive the advancement of discovery science in all of the aforementioned capacities.
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Rationale for Workshop
There are significant realized and potential benefits associated with the use of open data for discovery science. Unfortunately, despite such opportunities, the computational and informatics tools and methods currently used in most investigational settings to enable such efforts are often labor intensive and rely upon technologies that have not be designed to scale and support reasoning across heterogeneous and multi-dimensional data resources (1-3). As a result, there are significant demands from the research community for the creation and delivery of data management and data analytic tools capable of adapting to and supporting heterogeneous analytic workflows and open data sources (4-7). This need is particularly important when researchers seek to focus on the large-scale identification of linkages between bio-molecular and phenotypic data in order inform novel systems-level approaches to understanding disease states. In these types of situations, the scalar nature of such data exacerbates almost all of the aforementioned challenges. In this context, it is of interest to note that while the theoretical basis for the use of knowledgebased systems to overcome such challenges have evolved rapidly, their use in "real world" context remains the domain of experts with specialized training and unique access to such tools (1, 8, 9) .
All of the preceding issues are further amplified when considering the nature of modern approaches to hypothesis discovery and testing when exploring biological and clinical open data, which are often based on the intuition of the individual investigator or his/her team to identify a question that is of interest relative to their specific scientific aims, who then carry out hypothesis testing operations to validate or refine that question relative to a targeted data set (10, 11) . This approach is feasible when exploring data sets comprised of hundreds of variables, but does not scale to projects involve data sets with magnitudes on the order of thousands or even millions of variables (1, 8) . An emerging and increasingly viable solution to this particular challenge is the use of domain knowledge to generate hypotheses relative to the content of such data sets. This type of domain knowledge can be derived from many different sources, such as complementary and contextualizing databases, terminologies, ontologies, and published literature (8) . It is important to note, however, that methods and technologies that can allow researchers to access and extract domain knowledge from such sources, and apply resulting knowledge extracts to generate and test hypotheses are largely developmental at the current time (1, 8) .
Finally, even when the major hurdles to the regular use of open data for discovery science as noted above are adequately addressed, there remains a substantial reliance on the use of dataanalytic "pipelining" tools to ensure the systematic and reproducible nature of such data analysis operations. These types of pipelines are ideally able to support data extraction, integration, and analysis workflows spanning multiple sources, while capturing intermediate data analysis steps and products, and generating actionable output types (12, 13) . Using data-analytic pipelines provide a number of potential benefits, including: 1) they support the design and execution of data analysis plans that would not be tractable or feasible using manual methods; and 2) they provide for the capture meta-data describing the steps and intermediate products generated during such data analyses. In the case of the latter benefit, the ability to capture systematic meta-data is critical to ensuring that such in-silico research paradigms generate reproducible and high quality results (12, 13) . Again, while there are a number of promising technology platforms capable of supporting such data-analytic "pipelining", their widespread use is not robust, largely due to barriers to adoption related to data ownership/security, usability, scalability, and socio-technical factors (7, 14) .
Given the aforementioned challenges and opportunities and the current state of knowledge concerning the use of open data across and between types and scales for the purposes of discovery science, this workshop addresses the following major topic areas:
• The state-of-the-art in terms of tools and methods targeting the use of open data for discovery science, including but not limited to syntactic and semantic standards, platforms for data sharing and discovery, and computational workflow orchestration technologies that enable the creation of data analytics "pipelines"; • Practical approaches for the automated and/or semi-automated harmonization, integration, analysis, and presentation of "data products" to enable hypothesis discovery or testing; and • Frameworks for the application of open data to support or enable hypothesis generation and testing in projects spanning the basic, translational, clinical, and population health research and practice domains (e.g., from molecules to populations). 
